November 5th 2024
R. Lor Randall, MD, FACS, discusses the impact of race, ethnicity, and socioeconomic factors on outcomes in pediatric patients with nonmetastatic osteosarcoma.
August 15th 2024
R. Lor Randall, MD, FACS, discusses the role of EZH2 in doxorubicin resistance in soft tissue sarcoma.
June 14th 2023
R. Lor Randall, MD, FACS, discusses findings from a study of one-stage synovectomy in patients with diffuse-type tenosynovial giant cell tumor of the knee.
April 13th 2023
R. Lor Randall, MD, FACS, discusses the investigation of ganitumab plus standard-of-care interval-compressed chemotherapy in a phase 3 trial for newly diagnosed metastatic Ewing sarcoma.
March 24th 2023
R. Lor Randall, MD, FACS, discusses the potential symptoms and presentation of mesenchymal chondrosarcoma, as well as highlighted recent case studies that he consulted on for patients with mesenchymal chondrosarcoma.
March 20th 2023
R. Lor Randall, MD, FACS, discusses, the importance of correctly diagnosing mesenchymal chondrosarcoma.
January 6th 2022
R. Lor Randall, MD, FACS, discusses methods of preventing early failures with compressive osseointegrative endoprosthetic devices of the femur in bone sarcomas.
December 10th 2021
R. Lor Randall, MD, FACS, discusses the evolution of limb salvage technologies in bone sarcomas.
October 26th 2021
R. Lor Randall, MD, FACS, discusses initial considerations when treating patients with desmoid tumors.
November 16th 2020
R. Lor Randall, MD, FACS, discusses the evolution of orthopedic surgery in sarcoma.
February 14th 2020
R. Lor Randall, MD, FACS, discusses the SAFETY trial (NCT03944798) in soft tissue sarcoma.
January 30th 2020
R. Lor Randall, MD, FACS, discusses ongoing research in sequencing the tumors of patients with primary bone or tissue sarcomas.
October 9th 2019
R. Lor Randall, MD, FACS, discusses using pexidartinib to treat tenosynovial giant cell tumor.